Because CAPE upregulated p53 expression in p53 wild-type prostate carcinoma LNCaP cells, as shown in Figure 1A, we determined whether p53 affects MALT1 expression in prostate carcinoma cells. The gene discussed is TP53; the disease is prostate carcinoma.